Trademark Search in Canada

SWIRLY DESIGN

View On IC.GC.CA

REGISTERED

on 1 Nov 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

KRINGLE PHARMA INC.

2F Saito Bio Incubator, 7-7-15, Saitoasagi,Ibaraki- shiOsaka 567-0085

Serial Number

2159759 filed on 5^th Aug 2021

Registration Number

TMA1266824 registered on 1^st Nov 2024

Registration expiry Date

5^th Aug 2031

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

M5E1G4

SWIRLY DESIGN

Trademark usage description

stimulants for the central nervous system; hair growth stimulants; antipyretic analgesics; anti-epileptic pharmaceutical preparations; hypnotic sedati Read More

Vienna Information

2 . 9 . 22

Skeletons, bones (except 2.9.23)Squelettes, os (excepté 2.9.23)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

29 . 1 . 4

BlueBleu

Classification Information

Class [005]
Stimulants for the central nervous system; hair growth stimulants; antipyretic analgesics; anti-epileptic pharmaceutical preparations; hypnotic sedatives; general anesthetics; anti-motion sickness agents; pharmaceutical preparations acting on the peripheral nervous system for treating solitary peripheral neuritis, polyneuritis monopoly, polyneuritis, radial nerve palsy, median nerve palsy, ulnar nerve palsy, peroneal nerve palsy, tibial nerve palsy, facial palsy, Bell palsy, oppressive neuropathy, acute intermittent porphyria, chronic inflammatory demyelinating neuropathy, trigeminal neuralgia, diabetic neuropathy, vitamin B deficiency, pellagra, beriberi, polyarthritis nodosa, systemic lupus erythematosus, carpal tunnel syndrome, tarsal tunnel syndrome, elbow tunnel syndrome, back pain, allodynia, pain of finger, numbness of finger, Guillain-Barre syndrome, Charcot-Marie-Tooth disease, Familial amyloid polyneuropathy, Addictive neuropathy, cancer neuropathy, Crow-Fukase syndrome, Postherpetic neuralgia, Polyneuropathy, Polyradiculitis, Neronopathy, Mononeuropathy, Multiple mononeuropathy, Plexopathy; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics in the nature of pharmaceutical preparations for treating heart conditions; antispasmodics; diaphoretics; pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations, namely, nasal spray preparations, eye drops, eye washes; antiallergic agents; antihistamines; pharmaceutical preparations for the treatment of cardiovascular disease; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic agents; antiarrhythmic agents; diuretics; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; gastrointestinal cleaning agents; pharmaceutical preparations clysters in the nature of enema preparations; evacuants (purgatives); pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of dental and oral disease; emetics; antacids; antiemetics; castor oil (for medical purposes); cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; oxytocics; anti-hemorrhoidals; emmenagogues; oral contraceptives; injectable pharmaceutical contraceptives; medicated skin care preparations for treating, reducing, and preventing lines, pores, and loss of skin firmness; medicated skin care preparations for use as a moisturizer and a skin cleanser; pharmaceutical preparations for treating purulence wound; anti-dermoinfectives; antimicrobials for dermatologic use; astringents for medical purposes; anti-inflammatory agents; analgesics; anti-itching pharmaceutical preparations; talcum powder used for absorbing moisture; hair growth preparations; pharmaceutical preparations, namely, medicated baby oils for dermatologic use; medicated baby powders; medicated bath preparations for the treatment of irritated, itching and inflamed skin; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium pharmaceutical preparations; chondroitin preparations; pharmaceutical preparations, namely, protein dietary supplements and amino acid dietary supplements; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dermatitis, erythroderma, keratosis, dyschromatopsia, and lupus erythematosus; mineral preparations; anticoagulants; blood substitutes; blood plasma; hemostatics for medical purposes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antidotes; digestive enzymes used to treat pancreatic disease for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of drug and alcohol abuse; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; agents for treating physically caused lesions; heatstroke treating agents; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppressants; chlorine-detoxication agents; arsenic-detoxication agents; benzol-detoxication agents; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; pharmaceutical preparations, namely, colistin-polymixin; sarkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous drugs; sulfonamide preparations; antileprotic agents; biological preparations for medical purposes, namely, biological tissue grafts; antitoxic sera; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer; preparations for biological tests for medical purposes, namely, medical diagnostic reagents for testing of body fluids; toxoids, namely, vaccines against the flu; human vaccines; preparations for destroying parasites; anthelmintics; antiprotozoal agents; odor neutralizing preparations for use on hard surfaces that have had contact with odorous pharmaceuticals; diagnostic reagents and agents for medical diagnostic use; X-ray contrast agents; diagnostic media for bacteriological cultures; radio-isotope markers for therapeutic and diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations for medical purposes; acidifiers to increase levels of gastric acid to decrease stomach pH for veterinary purposes; anti-inflammatories, and cardiovascular agents for veterinary use; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants for domestic and agricultural use; herbicides (weedkillers); insect-repellents; antiseptics.

Classification kind code

Class [042]
Testing, inspection or research of pharmaceuticals and genetics for medical purposes; medical research; consultancy and providing information services relating to testing, inspection or research of pharmaceuticals and genetics for medical purposes; consultancy and providing information services relating to medical research.

Classification kind code

Mark Details

Serial Number

2159759

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 8^th Jul 2024	Agent Changed
Submitted for opposition 22 on 2^th May 2023	Search Recorded
Submitted for opposition 20 on 2^th May 2023	Examiner's First Report
Submitted for opposition 223 on 2^th May 2023	Total Provisional Refusal
Submitted for opposition 256 on 14^th Nov 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 13^th Jan 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 12^th Jan 2022	Formalized
Submitted for opposition 1 on 12^th Jan 2022	Created
Submitted for opposition 228 on 5^th Aug 2021	International Registration
Submitted for opposition 30 on 5^th Aug 2021	Filed